Eurobio Scientific Société anonyme (EPA:ALERS)
France flag France · Delayed Price · Currency is EUR
20.80
+0.80 (4.00%)
Aug 3, 2026, 12:54 PM CET

EPA:ALERS Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
168.6154.5682.28305.07167.43
Revenue Growth
9.08%87.85%-73.03%82.21%-55.67%
Cost of Revenue
91.7582.9948.181.6671.32
Gross Profit
76.8571.5734.1871.2496.11
Selling, General & Admin
52.9945.46243128.19
Depreciation & Amortization Expenses
3.783.756.735.94.09
Research & Development
---3.47-
Other Operating Expenses
9.339.03---
Total Operating Expenses
66.158.2430.7240.3732.28
Operating Income
10.7413.3312.2730.8770.04
Interest Income
-2.94-5.672.180.111.55
Interest Expense
---4.77-1.29-1.62
Other Non-Operating Income (Expense)
--1.38-0.71-0.670.11
Total Non-Operating Income (Expense)
-2.94-7.05-3.3-1.860.04
Pretax Income
7.816.289.6829.6869.97
Provision for Income Taxes
-2.94-2.290.83-4.757.74
Net Income
4.8748.1424.9462.34
Net Income to Common
4.8748.1424.9462.34
Net Income Growth
21.69%-50.88%-67.36%-60.00%-15.15%
Shares Outstanding (Basic)
1010111111
Shares Outstanding (Diluted)
1010111111
Shares Change
--8.63%-1.40%4.59%-3.35%
EPS (Basic)
0.470.390.432.205.58
EPS (Diluted)
0.470.390.432.205.57
EPS Growth
20.51%-9.30%-80.45%-60.50%-14.70%
Free Cash Flow
6.2813.4522.7140.2464.07
Free Cash Flow Growth
-53.28%-40.80%-43.55%-37.19%21.73%
Free Cash Flow Per Share
0.611.312.023.545.89
Gross Margin
45.58%46.30%41.55%23.35%57.40%
Operating Margin
6.37%8.63%14.91%10.12%41.83%
Profit Margin
2.89%2.59%9.89%8.17%37.24%
FCF Margin
3.73%8.70%27.60%13.19%38.27%
EBITDA
27.6830.3926.5240.0976.98
EBITDA Margin
16.42%19.66%32.23%13.14%45.98%
EBIT
10.7413.3312.2730.8770.04
EBIT Margin
6.37%8.63%14.91%10.12%41.83%
Effective Tax Rate
-37.67%-36.39%8.57%-15.99%11.06%